Skandinaviska Enskilda Banken Ab (Publ) Sana Biotechnology, Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $21.6 Billion
- Q4 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 189,472 shares of SANA stock, worth $598,731. This represents 0.0% of its overall portfolio holdings.
Number of Shares
189,472
Previous 583,489
67.53%
Holding current value
$598,731
Previous $2.43 Million
87.31%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding SANA
# of Institutions
177Shares Held
120MCall Options Held
1.79MPut Options Held
1.17M-
Flagship Pioneering Inc. Cambridge, MA25MShares$79 Million12.19% of portfolio
-
Black Rock Inc. New York, NY11MShares$34.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$34 Million0.0% of portfolio
-
Baillie Gifford & CO10.2MShares$32.3 Million0.01% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$32.2 Million0.02% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $601M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...